SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001764013-24-000039
Filing Date
2024-02-23
Accepted
2024-02-23 16:16:42
Documents
1
Period of Report
2024-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1708722983.html 4  
1 FORM 4 wk-form4_1708722983.xml 4 4171
  Complete submission text file 0001764013-24-000039.txt   5729
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNOVANT, INC. 320 WEST 37TH STREET, 6TH FLOOR NEW YORK NY 10018
Business Address
Macias William L. (Reporting) CIK: 0001864280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38906 | Film No.: 24671413